Article ; Online: Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment.
2023 Volume 132, Issue 10, Page(s) 1320–1337
Abstract: The current epidemic of corona virus disease (COVID-19) has resulted in an immense health burden that became the third leading cause of death and potentially contributed to a decline in life expectancy in the United States. The severe acute respiratory ... ...
Abstract | The current epidemic of corona virus disease (COVID-19) has resulted in an immense health burden that became the third leading cause of death and potentially contributed to a decline in life expectancy in the United States. The severe acute respiratory syndrome-related coronavirus-2 binds to the surface-bound peptidase angiotensin-converting enzyme 2 (ACE2, EC 3.4.17.23) leading to tissue infection and viral replication. ACE2 is an important enzymatic component of the renin-angiotensin system (RAS) expressed in the lung and other organs. The peptidase regulates the levels of the peptide hormones Ang II and Ang-(1-7), which have distinct and opposing actions to one another, as well as other cardiovascular peptides. A potential consequence of severe acute respiratory syndrome-related coronavirus-2 infection is reduced ACE2 activity by internalization of the viral-ACE2 complex and subsequent activation of the RAS (higher ratio of Ang II:Ang-[1-7]) that may exacerbate the acute inflammatory events in COVID-19 patients and possibly contribute to the effects of long COVID-19. Moreover, COVID-19 patients present with an array of autoantibodies to various components of the RAS including the peptide Ang II, the enzyme ACE2, and the AT |
---|---|
MeSH term(s) | Humans ; Male ; Female ; Renin-Angiotensin System/physiology ; COVID-19 ; Angiotensin-Converting Enzyme 2/metabolism ; Peptidyl-Dipeptidase A/physiology ; SARS-CoV-2 ; Sex Characteristics ; Post-Acute COVID-19 Syndrome ; Angiotensin-Converting Enzyme Inhibitors/pharmacology |
Chemical Substances | Angiotensin-Converting Enzyme 2 (EC 3.4.17.23) ; Peptidyl-Dipeptidase A (EC 3.4.15.1) ; Angiotensin-Converting Enzyme Inhibitors |
Language | English |
Publishing date | 2023-05-11 |
Publishing country | United States |
Document type | Journal Article ; Review ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't |
ZDB-ID | 80100-8 |
ISSN | 1524-4571 ; 0009-7330 ; 0931-6876 |
ISSN (online) | 1524-4571 |
ISSN | 0009-7330 ; 0931-6876 |
DOI | 10.1161/CIRCRESAHA.123.321883 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ui IV Zs.70: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
Ui IV Zs.60: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.